Form D · Pharmaceuticals

IRR, Inc.

Santa Barbara, CA · CIK 0001539828

Offering snapshot reported Dec 18, 2018 · SEC filing

Reported sold
$150K
Offering amount: $2M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 6, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 18, 2018Initial$150,000No comparison1SEC filing
Nov 24, 2017Initial$980,000No comparison2SEC filing
Oct 5, 2016Initial$15,000No comparison1SEC filing
Jul 7, 2015InitialYet to sellNo comparison0SEC filing
Dec 3, 2014Amendment$860,000No comparison21SEC filing
Jan 19, 2012InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
04
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-328339

Source: Form D, filed Dec 18, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Bruce Chandler May Director, Executive
Loriel May Director, Executive
B. Chandler May Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
515 East Micheltorena Street Suite G
Santa Barbara, CA, 93103